KLRS · Kalaris Therapeutics, Inc.
$3.40
+0.06 (+1.80%)
At close · Jul 29
Market Cap
$80.89M
Shares
23.79M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.